<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UCSC_Acetaminophen skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UCSC/Acetaminophen</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="button-custom"><DIV class="tiny-little-menu-word-above-button">MENU</DIV></DIV><UL><LI><A href="https://2017.igem.org/Team:UCSC/Judging">JUDGING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Notebook">NOTEBOOK</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Human_Practices">HUMAN PRACTICES</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Human_Practices">INTRODUCTION</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Safety">SAFETY</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Applied_Design">APPLIED DESIGN</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Engagement">EDUCATION</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Collaborations">COLLABORATIONS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/HP/Silver">SILVER</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/HP/Gold_Integrated">GOLD INTEGRATED</A></LI></UL><LI><A href="https://2017.igem.org/Team:UCSC/Project">PROJECT</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Project">THE PROJECT</A></LI><LI><A href="#">METABOLIC ENGINEERING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Acetaminophen">ACETAMINOPHEN</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/B-12">VITAMIN B<SUB>12</SUB></A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Model">MODELING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Demonstrate">RESULTS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Target-Organism">TARGET ORGANISM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Part_Collection">PARTS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/InterLab">INTERLAB STUDY</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Team">TEAM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Team">MEET THE TEAM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Attributions">ATTRIBUTIONS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC">HOME</A></LI><DIV id="page"><CENTER><H1>ACETAMINOPHEN METABOLICS</H1><DIV class="text-container"><DIV class="container"><P><SPAN class="quote">&quot;Antipyretic drugs, by being analgesics, reduce not only the fever but also the pain.&quot;</SPAN></P><DIV class="quote-person"> ~Clinical Manual of Fever in Children</DIV></DIV><P>We aim to genetically modify <I>S. elongatus</I> PCC 7942 to produce acetaminophen, a common mild anesthetic and antipyretic recognized by the WHO as an essential medicine<SUP>[1]</SUP>. However, in many countries with lower regulations and faulty policies regarding drug manufacturing, acetaminophen can be synthesized with lethal toxins that result in hundreds of deaths worldwide<SUP>[23]</SUP>.  Acetaminophen is often used in conjunction with opioid pain medications postoperatively to enhance pain relief, thus reducing reliance upon opioid pharmaceuticals<SUP>[24]</SUP>.</P><DIV class="metabolic-pathway"><FIGURE><FIGCAPTION>Current  synthetic  biology  approach  to  manufacturing  acetaminophen  in  <SPAN style="font-style: italic">E. coli</SPAN><SUP>[25, 26]</SUP>. Genes  <SPAN style="font-style: italic">4ABH</SPAN>  and  <SPAN style="font-style: italic">nhoA</SPAN>  were  inserted  to  synthesize  the  pathway  in  PCC  7942. The  gene  from  <SPAN style="font-style: italic">A. bisporus, 4ABH</SPAN>, produces 4-aminophenol while the <SPAN style="font-style: italic">E. coli</SPAN> gene <SPAN style="font-style: italic">nhoA</SPAN> converts that 4-aminophenol to acetaminophen <SUP>[25]</SUP>.</FIGCAPTION></FIGURE></DIV><P>We are using a previously engineered pathway in <SPAN style="font-style: italic">E. coli</SPAN> as a model of acetaminophen biosynthesis to enhance PCC 7942<SUP>[26, 25]</SUP>. The pathway converts chorismate, an abundant amino acid precursor of tryptophan, phenylalanine, and tyrosine, into acetaminophen with the addition ofthe <SPAN style="font-style: italic">4ABH</SPAN>gene from <SPAN style="font-style: italic">A. bisporus</SPAN>, an edible mushroom, and <SPAN style="font-style: italic">nhoA</SPAN> from <SPAN style="font-style: italic">E. coli</SPAN>. For more information on acetaminophen metabolics, check out <A href="https://2017.igem.org/Team:UCSC/Model">our modeling page!</A></P><DIV class="container" style="width: 100%"><DIV class="row"><DIV class="col-md-4"><H3>P R O J E C T</H3><A href="https://2017.igem.org/Team:UCSC/Project" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">HOMEPAGE</DIV></DIV></A></DIV><DIV class="col-md-8"><H3>Click here to learn more!</H3><DIV class="row"><A href="https://2017.igem.org/Team:UCSC/B-12" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">VITAMIN B<SUB>12</SUB></DIV></DIV></A><A href="https://2017.igem.org/Team:UCSC/Model" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">MODELING</DIV></DIV></A><A href="https://2017.igem.org/Team:UCSC/Demonstrate" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">RESULTS</DIV></DIV></A></DIV><DIV class="row"><A href="https://2017.igem.org/Team:UCSC/Target-Organism" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">TARGET ORGANISM</DIV></DIV></A><A href="https://2017.igem.org/Team:UCSC/Part_Collection" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">PARTS</DIV></DIV></A></DIV></DIV></DIV><DIV class="container"><DIV class="reference-list"><LI>[1] World  Health  Organization,  ed.,<SPAN class="reference-italic">The  Selection  and  Use  of  Essential  Medicines:   report  of  the WHO  Expert  Committee,  2007  ;  (including  the  15th  model  list  of  essential  medicines).</SPAN>  No. 946in WHO Technical Report Series, Geneva:  World Health Organization, 2007. OCLC: 254437808.</LI><LI>[23] P.  N.  Newton,  M.  D.  Green,  and  F.  M.  Fern ́andez,  “Impact  of  poor-quality  medicines  in  the‘developing’ world,”<SPAN class="reference-italic">Trends in Pharmacological Sciences</SPAN>, vol. 31, pp. 99–101, Mar. 2010.</LI><LI>[24]  S. A. Schug, D. A. Sidebotham, M. McGuinnety, J. Thomas, and L. Fox, “Acetaminophen as anadjunct to morphine by patient-controlled analgesia in the management of acute postoperativepain,”<SPAN class="reference-italic">Anesthesia and Analgesia</SPAN>, vol. 87, pp. 368–372, Aug. 1998.</LI><LI>[25] A. A. Menezes, J. Cumbers, J. A. Hogan, and A. P. Arkin, “Towards synthetic biological ap-proaches to resource utilization on space missions,”<SPAN class="reference-italic">Journal of the Royal Society, Interface</SPAN>, vol. 12,p. 20140715, Jan. 2015.</LI><LI>[26] J. C. Anderson, T. HSIAU, S. Srivastava, P. RUAN, J. P. I. KOTKER, R. BODIK, and S. A.Seshia, “Method  for  biosynthesis of acetaminophen,” May  2016. International ClassificationC12P13/02, C12N1/21; Cooperative Classification C12N9/1029, C12N9/0073, C12P13/02.</LI></DIV></DIV></DIV><FOOTER><DIV class="footer-box"><DIV class="col-md-5" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">S P O N S O R S</DIV><DIV class="col-md-2" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">S O C I A L </DIV></CENTER></DIV><DIV class="col-md-4" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">C O N T A C T</DIV><DIV class="address-of-our-team"><SPAN>Jack Baskin School of Engineering
    		University of California, Santa Cruz
    		1156 High Street
    		Santa Cruz, California, 95064</SPAN></DIV></CENTER></DIV></CENTER></DIV></DIV></FOOTER></DIV></CENTER></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>